Company profile for Maruho

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Maintaining good health has always been a major concern of people all over the world. As a pharmaceutical company, Maruho is addressing health problems with the utmost seriousness and sincerity. Everyone at Maruho is committed to their day-to-day activities, which are always informed by our Corporate Mission, "to contribute to better health for people all over the world" and our Corporate Credo "Pursuit of Truth." In order for...
Maintaining good health has always been a major concern of people all over the world. As a pharmaceutical company, Maruho is addressing health problems with the utmost seriousness and sincerity. Everyone at Maruho is committed to their day-to-day activities, which are always informed by our Corporate Mission, "to contribute to better health for people all over the world" and our Corporate Credo "Pursuit of Truth." In order for Maruho to fulfill this Corporate Mission, in 2002 we decided to dedicate ourselves to dermatology and topical drugs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Japan
Address
Address
1-5-22 Nakatsu, Kita-ku, Osaka
Telephone
Telephone
+81-6-6371-8876
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251023509795/en/Nielsen-BioSciences-Announces-Expanded-CANDIN-License-Agreement-with-Maruho-Co.-Ltd.

BUSINESSWIRE
23 Oct 2025

https://www.pharmabiz.com/NewsDetails.aspx?aid=169694&sid=2

PHARMABIZ
12 Jun 2024

https://www.prnewswire.com/news-releases/evommune-announces-strategic-collaboration-with-maruho-to-develop-and-commercialize-mrgprx2-antagonist-evo756-in-japan-301939507.html

PR NEWSWIRE
27 Sep 2023

https://www.businesswire.com/news/home/20220428005807/en

BUSINESSWIRE
28 Apr 2022

http://www.pharmabiz.com/NewsDetails.aspx?aid=147755&sid=2

PHARMABIZ
29 Mar 2022

https://www.globenewswire.com/news-release/2021/10/13/2313287/0/en/BiomX-Announces-Agreement-with-Maruho-Co-Ltd-for-Atopic-Dermatitis-Product-Candidate-BX005.html

GLOBENEWSWIRE
13 Oct 2021

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty